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COMPACT Predictions: Is
There a Catch?
Lewis et al. reported a retrospective evalua-
tion of COMPACT predictions of rodent
carcinogenicity for 44 chemicals evaluated
in long-term bioassays by the National
Toxicology Program (EHP 103:178-184).
They concluded that COMPACT per-
formed quite well. I was surprised to read
this, because I had seen the published
COMPACT carcinogenicity predictions
regarding these chemicals (1) and knew
that the method had not performed partic-
ularly well. Thus, I was interested in learn-
ing how the method's predictive perfor-
mance had been enhanced. After examin-
ing the paper by Lewis et al. (1) in more
detail, it quickly became clear that the
authors had employed several questionable
data manipulations in their retrospective
analysis to improve the performance of
their method.
Publishing predictions ofcarcinogenic-
ity before the study outcomes are known
firmly establishes the predictions and per-
mits an easy assessment of their accuracy.
Prospective predictions are important
because a predictive methodology that
truly works should be able to predict the
carcinogenic potential of untested chemi-
cals. Unfortunately, COMPACT had little
success in this regard. Based on Lewis et
al.'s predictions (1), COMPACT was able
to correctly predict the carcinogenicity
outcome for only 56% (20/36) ofthe NTP
chemicals, a success rate not significantly
different from flipping a coin. The 16
chemicals for which these COMPACT
predictions were inaccurate are given in
Table 1.
Given these results, it would have been
appropriate for the authors to attempt to
understand the reasons behind COMPACTs
failures and to make the necessary modifi-
cations so that the method might be more
successful when applied prospectively to a
new set of chemicals. Instead, the authors
reevaluated the predictions made for the
44 NTP chemicals and manipulated the
data in various ways to show that COM-
PACT (when used in combination with
Hazardexpert) really had only 5 discordant
carcinogenicity predictions, not 16. The
more important data manipulations are
discussed below.
Retrospective changes in the COM-
PACTpredictions. For two chemicals,
Lewis et al. changed their previously pub-
lished carcinogenicity predictions from posi-
tive to negative. For HC Yellow 4, the
authors stated in footnote b to Table 1 (p.
Table 1. Chemicals forwhich COMPACT incorrectly predicted carcinogenicity
NTP noncarcinogens predicted
to be carcinogens
Promethazine
Resorcinol
p-Nitrophenol
Tricresyl phosphate
Chloramine
4,4'-Diamino 2,2'-stilbenedisulfonic acid
Cl Pigment Red 23
4-Hydroxyacetanilide (acetaminophen)
HC Yellow4
p-Nitroaniline
NTP carcinogens predicted
to be noncarcinogens
o-Benzyl-p-chlorophenol
Methylphenidate hydrochloride
Diphenylhydantoin
Tris(2-chloroethyl)phosphate
2,3-Dibromo-1-propanol
1,2,3-Trichloropropane
Table 2. COMPACT and Hazardexpert predictions for six NTP equivocal carcinogens
COMPACT Hazardexpert Carcinogenicity
Chemical prediction prediction outcome
y-Butyrolactone
Chloramine +
Cl Pigment Red 23 + + +
4-Hydroxyacetanilide + - +
HC Yellow4 +
p-Nitroaniline + + +
aThese carcinogenicity outcomes reflectthe views of Lewis etal., notthe conclusions ofthe NTP. Lewis
et al. concluded thatthe carcinogenicity outcomes for all six chemicals were predicted correctly by
COMPACT/Hazardexpert.
179) thatwhile their original prediction was
positive, "calculation based on new struc-
ture gives negative." For resorcinol, the
authors apparently justify the changed pre-
diction byasserting that "the original graph-
ical analysis was clearly negative." However,
the paper they cite to justify the negative
graphical analysis is their previous paper (1),
in which they clearly report their carcino-
genicity prediction for resorcinol to be posi-
tive, not negative. Both changes result in
correct predictions, reducing the number of
discordant predictions from 16 to 14.
Reinterpretation ofNTP's equivocal
carcinogenicity results. Equivocal respons-
es often occur in rodent carcinogenicity
studies. Lewis et al. state that for assessing
concordance "when this single [the car-
cinogenicity] response is EE (equivocal evi-
dence), the overall response is . . . taken as
'- in the final assessment" (pp. 178-179).
This is a reasonable approach, but the
authors did not follow this rule when
assessing the predictive performance of
COMPACT.
There were nine NTP chemicals for
which only equivocal evidence of carcino-
genicity was observed. For three equivocal
carcinogens predicted by COMPACT to
be positive (CI pigment red 23, 4-hydroxy-
acetanilide, and p-nitroaniline), the
authors reevaluated the results and con-
cluded that these studies were "weak posi-
tives/equivocal positives based on patholo-
gy reports" (Table 2, p. 180), and thus
their predictions that the chemicals would
be carcinogens were correct after all. This
reduced the number of discordant predic-
tions from 14 to 11.
The source of the "pathology reports"
is not given, but clearly Lewis et al.'s inter-
pretation of these studies does not reflect
the views of the NTP, which concluded
that these three bioassays showed equivo-
cal, not weakly positive, carcinogenic
effects (as did the other six chemicals
showing equivocal responses). There are
several reasonable options for dealing with
equivocal carcinogenicity outcomes. One is
to regard them all as positive or all as nega-
tive (the latter being the rule the authors
claim to have followed, as noted previous-
ly). Alternatively, chemicals with equivocal
or uncertain findings could be excluded
from consideration altogether when evalu-
ating predictive methodologies. Less defen-
sible is the strategy used by the authors,
who attempted to distinguish between
"equivocal positives" (which they consid-
ered positive) and "equivocal negatives"
(which they considered negative).
COMPACT predicted carcinogenicity
outcomes for six ofthe nine NTP equivocal
carcinogens, and these predictions are sum-
marized in Table 2, together with the Lewis
et al. interpretation of the carcinogenicity
outcomes. The authors concluded that all six
chemicals are predicted correctly by COM-
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PACT/Hazardexpert. However, by the rule
they claim to have used (equivocal carcino-
gens are regarded as noncarcinogens), onlyy-
butyrolactone is predicted correctly.
Inclusion ofadditional related vari-
ables in thepredictive method. After the
carcinogenicity outcomes were known,
Lewis et al. found that the predictive per-
formance of COMPACT could be
enhanced if they included an additional
COMPACT prediction (C2E) and also a
predictor variable ("Hazardexpert") that
incorporates information about metabo-
lism. While there is nothing inherently
wrong with including additional variables
in a predictive methodology, this exercise
should ideally have been carried out
prospectively, not retrospectively. It is
much easier to find predictive variables
that work once the study outcomes to be
predicted are known. The important (and
yet to be answered) question is, how will
the authors' newly derived, multivariate
predictive methodology fare for prospec-
tive predictions? Hopefully, it will be bet-
ter than COMPACT's limited predictive
success (56%) for the 44 NTP chemicals.
The combination of COMPACT and
Hazardexpert eliminated the apparent dis-
cordance for three chemicals: tris(2-
chloroethyl)phosphate, 2,3-dibromo-1-
propanol, and 1,2,3-trichloropropane,
while introducing discordance for another
chemical previously predicted correctly
(methyl bromide). However, the authors
misclassify two other chemicals: chlo-
ramine and HC Yellow 4, both of which
are reported as successful predictions, but
in fact were not predicted correctly (see
Table 2). Including additional predictor
variables (and not correcting for the mis-
classification of chloramine and HC
Yellow 4) reduced the number of discor-
dant predictions from 11 to 8.
Inclusion ofadditional, apparently
unrelated, variables in the predictive
method. The eight chemicals that Lewis et
al. conclude are not correctly predicted by
COMPACT/Hazardexpert are designated
in their Table 4 (p. 182). The authors then
carry out further analyses to reduce the
number of discordant predictions from
eight to five. Frankly, it is unclear exactly
how the authors achieve this reduction. It
appears that the basis for eliminating the
final three chemicals from "discordancy"
was an appeal to "structural alert, chronic
toxicity studies, and the Ames test," which
correctly predicted the carcinogenicity of
o-benzyl-p-chlorophenol, methylphenidate
hydrochloride, and diphenylhydantoin,
three chemicals "missed" by COM-
PACT/Hazardexpert. One other chemical
(mercuric chloride) not even evaluated by
COMPACT/Hazardexpert, but correctly
identified by "the metal ion redox poten-
tials for inorganic compounds," was also
apparently added in as a correct prediction.
The authors should justify how these addi-
tional predictions, based on apparently
unrelated variables, can be meaningfully
interpreted as improving the performance
ofCOMPACT/ Hazardexpert. In any case,
the authors include these successful predic-
tions in their calculations and conclude
that the concordance for COMPACT/
Hazardexpert when predicting rodent car-
cinogenicity is 86% (32/37). I leave it to
the reader's judgment to determine how
much confidence to place in this figure.
I have no objection to the development
of techniques designed to predict rodent
(or more importantly, human) carcino-
genicity, and I suspect that it is possible to
develop methods that will be successful in
this regard. However, I strongly urge cau-
tion in placing too much confidence in
COMPACT or in any other predictive
method that has little success when applied
prospectively and seems to work onlywhen
applied retrospectively to the original data
set, using extensive (and scientifically ques-
tionable) data manipulations and reanalysis.
Joseph K. Haseman
National Institute ofEnvironmental
Health Sciences
Research Triangle Park, North Carolina
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Response
In response to Joe Haseman's letter, we
would like to point out that although our
article is retrospective with regard to the
rodent carcinogenicity study of the 40
chemicals, the COMPACT data were avail-
able at the time of the release of the car-
cinogenicity assays. The Hazardexpert eval-
uations for the 40 chemicals were carried
out after the NIEHS conference, but the
Hazardexpert system (available commer-
cially from Compudrug Ltd) is not part of
COMPACT. The following account, hope-
fully, provides some clarification of the
points raised in Dr. Haseman's letter.
Most other systems publish their pre-
dictions or analyses without providing any
mathematical derivation which can be
reproduced by others. In contrast, we show
how our predictions/analyses are generated
from numerical values (COMPACT para-
meters) for molecular and electronic fea-
tures of each chemical. Our attempts to
provide a numerical description of the
COMPACT plot of molecular planarity/
potential chemical reactivity, have not
been entirely successful, due to the fact
that the training set of chemicals shows a
curved line discriminating P4501 specifici-
ty from other P450 isozymes, whereas the
COMPACT ratio (either area/depth2/AE
or area/depth2/AE - 8) gives a straight line
relationship. This results in some chemi-
cals (e.g., resorcinol) having a COMPACT
ratio and a COMPACT graphical plot
which give conflicting results, but the
graph is the original paradigm. We have
recently derived an expression which is
more complex (1), based on analysis ofthe
COMPACT curve, and this gives more
precise results in terms of correlation with
the graph, although the actual graphical
representation is preferred.
Resorcinol was predicted to be positive
in COMPACT using the COMPACT
ratio, but the graph of area/depth2 versus
AE as presented at the 1993 NTP confer-
ence (2) clearly shows that this compound
should be negative as it is outside the
curve. This is the only example in all ofthe
40 chemicals of a discrepancy between the
approximation of the COMPACT ratio
and the accurate description of the graph.
As the EHP paper is retrospective, we feel
justified in making this point, even though
the graphical description was available in
the conference documentation. HC Yellow
4 was changed from positive in COM-
PACT to negative, due to the fact that the
original structure sent to us by NTP was
erroneous and was subsequently changed
by NTP after our original predictions had
been published. When we ran the new
(correct) structure through our system, it
proved negative, and we feel justified in
making this clear in our retrospective study
published in EHP. However, we provided
revised data (including the aforementioned
cases) and distributed this at the NTP con-
ference, which, moreover, included our
results for the P4502E descriptor, now
provided in the February 1995 issue of
EHP(103:178-184).
The Hazardexpert analyses were gener-
ated retrospectively as we had only recently
purchased the software. As can be seen
from our EHP paper, the Hazardexpert
results (which utilize the EPA database)
give quite good concordances with positive
carcinogens, and they are better than the
Ames test for negatives and also overall.
Regarding the relatively poor perfor-
mance of the original computer-based pre-
dictions compared with that of Ashby,
Tennant, and others, it should be empha-
sized that the latter employed a combina-
tion of mutagenicity, subchronic toxicity,
and structural alert tests, which are, there-
fore, three evaluations combined into one
prediction-so it is perhaps not surprising
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